These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 19147322)

  • 1. Regarding "Altered fibrin clot structure and function in individuals with intermittent claudication".
    Bhasin N; Parry DJ; Scott DJ; Ariëns RA; Grant PJ; West RM
    J Vasc Surg; 2009 Apr; 49(4):1088-9. PubMed ID: 19147322
    [No Abstract]   [Full Text] [Related]  

  • 2. Altered fibrin clot structure and function in the healthy first-degree relatives of subjects with intermittent claudication.
    Bhasin N; Ariëns RA; West RM; Parry DJ; Grant PJ; Scott DJ
    J Vasc Surg; 2008 Dec; 48(6):1497-503, 1503.e1. PubMed ID: 18829228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibrinolytic risk factor clustering and insulin resistance in healthy male relatives of men with intermittent claudication.
    Parry DJ; Grant PJ; Scott DJ
    Br J Surg; 2006 Mar; 93(3):315-24. PubMed ID: 16498597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heritability of clot formation, morphology, and lysis: the EuroCLOT study.
    Carter AM; Cymbalista CM; Spector TD; Grant PJ;
    Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2783-9. PubMed ID: 17932316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endogenous heparin activity is decreased in peripheral arterial occlusive disease.
    Shankar VK; Handa A; Hands L
    J Vasc Surg; 2008 May; 47(5):1033-8. PubMed ID: 18328667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How many claudicants should be prescribed statins?
    Harrison EM; Holdsworth RJ
    Eur J Vasc Endovasc Surg; 2003 Apr; 25(4):367-8. PubMed ID: 12651177
    [No Abstract]   [Full Text] [Related]  

  • 7. Relationship of the platelet glycoprotein PlA and fibrinogen T/G+1689 polymorphisms with peripheral arterial disease and ischaemic heart disease.
    Smith FB; Connor JM; Lee AJ; Cooke A; Lowe GD; Rumley A; Fowkes FG
    Thromb Res; 2003; 112(4):209-16. PubMed ID: 14987913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abnormal circulating levels of metalloprotease 9 and its tissue inhibitor 1 in angiographically proven peripheral arterial disease: relationship to disease severity.
    Tayebjee MH; Tan KT; MacFadyen RJ; Lip GY
    J Intern Med; 2005 Jan; 257(1):110-6. PubMed ID: 15606382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Percutaneous angioplasty, endothelial markers, and fibrin turnover.
    Woodburn KR; Lowe GD; Pollock JG; Rumley A; Reid AW
    J Endovasc Surg; 1994 Sep; 1():53-60. PubMed ID: 9234105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intermittent claudication: a plea for guidelines for medical management.
    Powell JT
    Eur J Vasc Endovasc Surg; 2007 Apr; 33(4):451-2. PubMed ID: 17196850
    [No Abstract]   [Full Text] [Related]  

  • 11. D-dimer and platelet aggregation and peripheral arterial disease.
    Greenhalgh R
    Eur Heart J; 2002 Aug; 23(16):1241-2. PubMed ID: 12175660
    [No Abstract]   [Full Text] [Related]  

  • 12. Control of hypertension in patients with peripheral artery disease.
    Clement DL
    Blood Press; 2006; 15(4):251-2. PubMed ID: 17078187
    [No Abstract]   [Full Text] [Related]  

  • 13. Intermittent claudication.
    Emmerich J; Messas E; Fiessinger JN
    N Engl J Med; 2007 Jul; 357(1):91-2; author reply 92-3. PubMed ID: 17611216
    [No Abstract]   [Full Text] [Related]  

  • 14. Plasma levels of beta(2)-microglobulin, a biomarker of peripheral arterial disease, are not affected by maximal leg exercise in patients with intermittent claudication.
    Busti C; Migliacci R; Falcinelli E; Gresele P
    Atherosclerosis; 2009 Mar; 203(1):38-40. PubMed ID: 18674763
    [No Abstract]   [Full Text] [Related]  

  • 15. Anti-chlamydial antibiotic therapy for symptom improvement in peripheral artery disease: prospective evaluation of rifalazil effect on vascular symptoms of intermittent claudication and other endpoints in Chlamydia pneumoniae seropositive patients (PROVIDENCE-1).
    Jaff MR; Dale RA; Creager MA; Lipicky RJ; Constant J; Campbell LA; Hiatt WR
    Circulation; 2009 Jan; 119(3):452-8. PubMed ID: 19139383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-platelet therapy: is it all over in peripheral artery disease?
    Jaipersad AS; Silverman SH; Lip GY
    Thromb Haemost; 2010 Apr; 103(4):689-91. PubMed ID: 20174749
    [No Abstract]   [Full Text] [Related]  

  • 17. Ankle-brachial index and peripheral arterial disease.
    Lamina C; Meisinger C; Heid IM; Rantner B; Döring A; Löwel H; Wichmann HE; Kronenberg F
    Gesundheitswesen; 2005 Aug; 67 Suppl 1():S57-61. PubMed ID: 16032518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of (a)symptomatic peripheral arterial disease; the additional value of ankle-brachial index on cardiovascular risk stratification.
    van Kuijk JP; Flu WJ; Bax JJ; Poldermans D
    Eur J Vasc Endovasc Surg; 2009 Sep; 38(3):312-3. PubMed ID: 19524459
    [No Abstract]   [Full Text] [Related]  

  • 19. Coagulation in diabetic and non-diabetic claudicants.
    Gosk-Bierska I; Adamiec R; Alexewicz P; Wysokinski WE
    Int Angiol; 2002 Jun; 21(2):128-33. PubMed ID: 12110772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peripheral arterial disease and Virchow's triad.
    Bennett PC; Silverman SH; Gill PS; Lip GY
    Thromb Haemost; 2009 Jun; 101(6):1032-40. PubMed ID: 19492144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.